Member Info for Visainn

Buyers either caught by myth, or hoping for reality

Lets see - two hours to go

NOOO

There are MANY tests that can detect the latest strain - what this test does is ONLY test for THIS PARTICULAR strain (So if you are sick with anything else it wont detect)

That is why its novel - as a wide range test can say you are sick - but not determine if it is Corona or not - Which this test does

Here's the way I see it

Firstly this was 6 in October (so 600% up at the peak couple of days ago)

Secondly, there is competition (The whole world is scrambling and every pharmaceutical laboratory creating tests and seeking the holy grail.)

Thirdly if you look at RNS before Corona disaster - there were finding issues, and arround 90% of late last year's orders had NOT been filled due to lack of capital

So the issue is: a) They have a test (YES) b) Are they receiving orders (One would presume YES) but critically do they have the funds and manufacturing ability to fulfil the orders. That s the question.

As recently as January this year (LAST MONTH) the company in their results said:

The Company has started 2020 with an order book significantly higher than at the same time last year. Lab21 Products had confirmed orders of €1.6m at the end of the year. Of these orders, €1.3m could not be delivered due to working capital and supply chain issues and are expected to be fulfilled during the first half of 2020.

That was BEFORE Corona - so this is in addition to the already backlog of orders in other products.
Company needs to release a RNS clearly on orders and profitability here.

People trying to hold up the price no matter what

https://www.caixinglobal.com/2020-01-29/genome-giant-bgi-gets-regulator-approval-to-sell-coronavirus-test-kits-101509268.html

No market direct to China

https://www.wired.com/story/the-us-fast-tracked-a-coronavirus-test/

Firstly remind me not to post from mobile .. apologies for the English earlier. .

I’m still holding and sentiment remains.

Next RNS will be results in March and therefore holders have time to move holdings from here to greener (temporary)pasture (or Aim dessert camouflaged as green) and come back prior to results.

For me I’m switching off now to mid Feb .. see where SP is by then, and watch into the results.

In any event holding to either recovery within reason of previous SP ( 25% less than the £10 was trading) or a buyout.

Solid company .. no shocks expected ??

Problem is that with share like this very unlikely to get RNS out of the blue

Lots tooknpoditions expecting to rocket on update. Now gone and next news is results in March do people sell and move else where to gone back in before results

In the short term this will rerate to £3 plus

Medium term - £5

Long term £7 to £8 or buy out at that level

Clear underlying message - IMprovement Improvement Improvement plus higher margins and free of shackles of loss leading contracts.

Add this to commercial agreements signed for new offices next year, a BOD that holds more than 50% of the shares, and the commitments benefiting cash flow all point to a recovery play here

I am holding this for the long game - £7 to £8 and return to dividends

Up we go

Long awaited - but all looking good.

LSE shows 2 RNS but only details of one

London Stock exchange showing one.

Anyone know of anything else

Share price that is

Its all in the NAME Wontago... and in your case you WONTAGO DOWN.

Its all a gamble - but im feeling that LAdy Luck is with me here.

Cash balance at period end £1.9m (H1 2018: £5.8m) with £0.7m banked post period end

(This is misleading as it implies 1.9 Million PLUS 0.7 available in CASH - However the 0.7 simply says BANKED and does NOT account for spending post period)

NO...

In September RNS Bobby said ...New sales office in Leicester, increasing the team to 40 people; and investment in a new automated sales platform. Plans to extend sales operation further with the development of a new purpose-built office

So at that time it was a PLAN to grow to 40 and a PLAN to develop a new purpose-built-office.

The NEW RNS now goes much further and confirms that they have SOURCED (No longer planned) a purpose built office (AGREED COMMERCIAL TERMS ...i.e. signed on the bottom line) to move into next year - with space NOT For 40 .. but up to 400.

Brilliant release of news prior to update due next week.

GROWING business ... GROWING staff ... CUSTOM BUILT premises ... Parking for 250 and office to grow to staff of 400

Yes bloody YES.

TICK TOCK TICK TOCK

Update coming - that's guaranteed

We will see some upward momentum through to end of month

Looking at this disappointing RNS again another thing just struck me.

They SOLD SKIN shares (which were ASSETS of Opti) and have included the sale of ASSETS as INCOME to profitability

GO check RNS